Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Creative Medical Technology Holdings (CELZ) over the last 15 years, with Q1 2025 value amounting to -$39920.0.

  • Creative Medical Technology Holdings' Change in Accured Expenses changed N/A to -$39920.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$36920.0, marking a year-over-year decrease of 133066.67%. This contributed to the annual value of $15535.0 for FY2022, which is 2471.53% down from last year.
  • Per Creative Medical Technology Holdings' latest filing, its Change in Accured Expenses stood at -$39920.0 for Q1 2025.
  • Creative Medical Technology Holdings' Change in Accured Expenses' 5-year high stood at $35000.0 during Q2 2022, with a 5-year trough of -$39920.0 in Q1 2025.
  • Over the past 4 years, Creative Medical Technology Holdings' median Change in Accured Expenses value was $1907.0 (recorded in 2021), while the average stood at -$75.0.
  • The largest annual percentage gain for Creative Medical Technology Holdings' Change in Accured Expenses in the last 5 years was 11434.26% (2022), contrasted with its biggest fall of 132850.12% (2022).
  • Creative Medical Technology Holdings' Change in Accured Expenses (Quarter) stood at -$5534.0 in 2021, then tumbled by 171.05% to -$15000.0 in 2022, then surged by 120.0% to $3000.0 in 2024, then tumbled by 1430.67% to -$39920.0 in 2025.
  • Its Change in Accured Expenses stands at -$39920.0 for Q1 2025, versus $3000.0 for Q3 2024 and -$15000.0 for Q4 2022.